Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September and, according to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

President-elect Donald Trump said on Thursday he has selected Robert F. Kennedy Jr., an environmental activist who has spread ...

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...